» Articles » PMID: 33595821

Pharmacological Properties of Baicalin on Liver Diseases: a Narrative Review

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2021 Feb 17
PMID 33595821
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Baicalin is the main active component of Scutellaria baicalensis, widely used in traditional Chinese medicine thanks to its various pharmacological effects, such as anti-tumor, anti-inflammatory, and antibacterial properties, as well as cardiovascular, hepatic, and renal protective effect. Recently, the protective effects of baicalin on liver disease have received much more attention. Several studies showed that baicalin protects against several types of liver diseases including viral hepatitis, fatty liver disease, xenobiotic induced liver injury, cholestatic liver injury, and hepatocellular carcinoma, with a variety of pharmacological mechanisms. A comprehensive understanding of the mechanism of baicalin can provide a valuable reference for its clinical use, but up to now, no narrative review is available that summarizes the pharmacological effects of baicalin to clarify its potential use in the treatment of liver diseases. Therefore, this review summarizes the progress of baicalin research and the underlying mechanism in the treatment of various liver diseases, to promote further research and its clinical application.

Citing Articles

Baicalin plays a protective role by regulating ferroptosis in multiple diseases.

Guo S, Zhang Q, Ge H, Wang H Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39661143 DOI: 10.1007/s00210-024-03704-5.


The therapeutic effects of Paeoniae Radix Rubra on chronic hepatitis through network pharmacology and molecular docking.

Yu C, Yang F, Zou Y, Zhang Y, Pan S Medicine (Baltimore). 2024; 103(49):e40796.

PMID: 39654159 PMC: 11630941. DOI: 10.1097/MD.0000000000040796.


Therapeutic potential of flavonoids from traditional Chinese medicine in pancreatic cancer treatment.

Wan Q, Ren Q, Qiao S, Lyu A, He X, Li F Front Nutr. 2024; 11:1477140.

PMID: 39650709 PMC: 11620852. DOI: 10.3389/fnut.2024.1477140.


Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation.

Zheng S, Qi W, Xue T, Zao X, Xie J, Zhang P Heliyon. 2024; 10(20):e39176.

PMID: 39640799 PMC: 11620126. DOI: 10.1016/j.heliyon.2024.e39176.


Baicalein Long-Circulating Liposomes Improve Histological and Functional Outcomes After Traumatic Brain Injury.

Yuan D, Xu W, Raza F, Zafar H, Guan S, Wang Z Adv Pharmacol Pharm Sci. 2024; 2024:2869332.

PMID: 39624070 PMC: 11611450. DOI: 10.1155/adpp/2869332.


References
1.
Mokdad A, Lopez A, Shahraz S, Lozano R, Mokdad A, Stanaway J . Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014; 12:145. PMC: 4169640. DOI: 10.1186/s12916-014-0145-y. View

2.
Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M . Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017; 131:68-80. DOI: 10.1016/j.ejmech.2017.03.004. View

3.
Fang P, Yu M, Shi M, Bo P, Gu X, Zhang Z . Baicalin and its aglycone: a novel approach for treatment of metabolic disorders. Pharmacol Rep. 2020; 72(1):13-23. DOI: 10.1007/s43440-019-00024-x. View

4.
Liang W, Huang X, Chen W . The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review. Aging Dis. 2018; 8(6):850-867. PMC: 5758355. DOI: 10.14336/AD.2017.0829. View

5.
Kuo Y, Lin C, Kuo H, Hung J, Liu C, Jassey A . Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways. J Food Drug Anal. 2019; 27(1):240-248. PMC: 9298638. DOI: 10.1016/j.jfda.2018.07.002. View